357 related articles for article (PubMed ID: 14512209)
1. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.
Vermetten E; Vythilingam M; Southwick SM; Charney DS; Bremner JD
Biol Psychiatry; 2003 Oct; 54(7):693-702. PubMed ID: 14512209
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment.
Fani N; Kitayama N; Ashraf A; Reed L; Afzal N; Jawed F; Bremner JD
Psychopharmacol Bull; 2009; 42(1):53-68. PubMed ID: 19204651
[TBL] [Abstract][Full Text] [Related]
3. Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder.
Bremner JD; Vermetten E
Ann N Y Acad Sci; 2004 Dec; 1032():154-7. PubMed ID: 15677402
[TBL] [Abstract][Full Text] [Related]
4. The relationship between hippocampal volume and declarative memory in a population of combat veterans with and without PTSD.
Tischler L; Brand SR; Stavitsky K; Labinsky E; Newmark R; Grossman R; Buchsbaum MS; Yehuda R
Ann N Y Acad Sci; 2006 Jul; 1071():405-9. PubMed ID: 16891587
[TBL] [Abstract][Full Text] [Related]
5. Deficits in verbal declarative memory function in women with childhood sexual abuse-related posttraumatic stress disorder.
Bremner JD; Vermetten E; Afzal N; Vythilingam M
J Nerv Ment Dis; 2004 Oct; 192(10):643-9. PubMed ID: 15457106
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cognitive and brain changes in posttraumatic stress disorder.
Bremner JD
Ann N Y Acad Sci; 2006 Jul; 1071():80-6. PubMed ID: 16891564
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment.
Vythilingam M; Vermetten E; Anderson GM; Luckenbaugh D; Anderson ER; Snow J; Staib LH; Charney DS; Bremner JD
Biol Psychiatry; 2004 Jul; 56(2):101-12. PubMed ID: 15231442
[TBL] [Abstract][Full Text] [Related]
8. Treatment of posttraumatic stress disorder: the impact of paroxetine.
Davidson JR
Psychopharmacol Bull; 2003; 37 Suppl 1():76-88. PubMed ID: 14566203
[TBL] [Abstract][Full Text] [Related]
9. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.
Marshall RD; Schneier FR; Fallon BA; Knight CB; Abbate LA; Goetz D; Campeas R; Liebowitz MR
J Clin Psychopharmacol; 1998 Feb; 18(1):10-8. PubMed ID: 9472837
[TBL] [Abstract][Full Text] [Related]
10. Increased neural response to trauma scripts in posttraumatic stress disorder following paroxetine treatment: A pilot study.
Fani N; Ashraf A; Afzal N; Jawed F; Kitayama N; Reed L; Bremner JD
Neurosci Lett; 2011 Mar; 491(3):196-201. PubMed ID: 21256927
[TBL] [Abstract][Full Text] [Related]
11. Cortisol, learning, memory, and attention in relation to smaller hippocampal volume in police officers with posttraumatic stress disorder.
Lindauer RJ; Olff M; van Meijel EP; Carlier IV; Gersons BP
Biol Psychiatry; 2006 Jan; 59(2):171-7. PubMed ID: 16154543
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacotherapy for post-traumatic stress disorder.
Davis LL; Frazier EC; Williford RB; Newell JM
CNS Drugs; 2006; 20(6):465-76. PubMed ID: 16734498
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal volume and declarative memory function in combat-related PTSD.
Woodward SH; Kaloupek DG; Grande LJ; Stegman WK; Kutter CJ; Leskin L; Prestel R; Schaer M; Reiss AL; Eliez S
J Int Neuropsychol Soc; 2009 Nov; 15(6):830-9. PubMed ID: 19703322
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
[TBL] [Abstract][Full Text] [Related]
15. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder.
Bremner JD; Vythilingam M; Vermetten E; Southwick SM; McGlashan T; Nazeer A; Khan S; Vaccarino LV; Soufer R; Garg PK; Ng CK; Staib LH; Duncan JS; Charney DS
Am J Psychiatry; 2003 May; 160(5):924-32. PubMed ID: 12727697
[TBL] [Abstract][Full Text] [Related]
16. Altered spontaneous neuronal activity in chronic posttraumatic stress disorder patients before and after a 12-week paroxetine treatment.
Zhu H; Qiu C; Meng Y; Cui H; Zhang Y; Huang X; Zhang J; Li T; Gong Q; Zhang W; Lui S
J Affect Disord; 2015 Mar; 174():257-64. PubMed ID: 25527996
[TBL] [Abstract][Full Text] [Related]
17. Emotion Regulatory Brain Function and SSRI Treatment in PTSD: Neural Correlates and Predictors of Change.
MacNamara A; Rabinak CA; Kennedy AE; Fitzgerald DA; Liberzon I; Stein MB; Phan KL
Neuropsychopharmacology; 2016 Jan; 41(2):611-8. PubMed ID: 26111649
[TBL] [Abstract][Full Text] [Related]
18. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
[TBL] [Abstract][Full Text] [Related]
19. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder.
Bremner JD; Randall P; Scott TM; Bronen RA; Seibyl JP; Southwick SM; Delaney RC; McCarthy G; Charney DS; Innis RB
Am J Psychiatry; 1995 Jul; 152(7):973-81. PubMed ID: 7793467
[TBL] [Abstract][Full Text] [Related]
20. Stress and brain atrophy.
Bremner JD
CNS Neurol Disord Drug Targets; 2006 Oct; 5(5):503-12. PubMed ID: 17073653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]